---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-21-003064"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2021-12-07T23:59:59+00:00"
generated_at: "2026-06-28T03:10:53.072146+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences grants CEO Gregory Gorgas option for 1.355M shares at $0.63

## Summary
- Option to purchase 1,355,000 shares of common stock at exercise price of $0.63 per share.
- Granted on December 3, 2021 under the 2018 Equity Incentive Plan.
- Vesting: 25% on December 3, 2022; remaining shares vest ratably monthly over 36 months.
- Continued service as a Service Provider required for vesting.

## SEC filing metadata
- accession: 0001640334-21-003064
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2021-12-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033421003064/0001640334-21-003064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033421003064/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-21-003064
- JSON: https://secwatch.observer/filing/0001640334-21-003064.json
- Plain text: https://secwatch.observer/filing/0001640334-21-003064.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.